Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2003
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/09/2003US6660233 Analytical biochemistry system with robotically carried bioarray
12/09/2003US6660229 Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing
12/09/2003US6660228 Apparatus for performing heat-exchanging, chemical reactions
12/09/2003US6660147 High density electrophoresis device and method
12/09/2003CA2387284C Chinese herbs extract
12/09/2003CA2356364C Cholesterol sensor and method for determining cholesterol
12/09/2003CA2266543C Methods and compositions for identifying receptor effectors
12/09/2003CA2104110C Nucleic acid fragment from the chromosome x region involved in the fragile x syndrome, nucleotide probe and method for the diagnosis of mental retardation with fragile x
12/06/2003CA2423832A1 Method and apparatus for detecting bacteria
12/04/2003WO2003100557A2 Computer systems and methods for subdividing a complex disease into component diseases
12/04/2003WO2003100541A2 Methods for profiling molecules with an objective function
12/04/2003WO2003100438A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003WO2003100437A1 Method for identifying type-i interferon responsive ms patients by determining trail expression
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100432A2 Method for identifying immunoreactive peptides
12/04/2003WO2003100431A1 Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11)
12/04/2003WO2003100430A1 Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell
12/04/2003WO2003100427A1 Method for identification of a ligand whereby receptor residence time is measured
12/04/2003WO2003100422A1 Dna microarray data processing method, dna microarray data processing system, dna microarray data processor, program and recording medium
12/04/2003WO2003100420A2 Electrochemical enzyme immunoassay for simultaneously detecting a number of analytes
12/04/2003WO2003100418A2 Method and kit for measuring mitochondrial activity in isolated cells
12/04/2003WO2003100413A2 Surface acoustic wave sensors and methods for detecting target analytes
12/04/2003WO2003100402A1 Method and apparatus for measuring white blood cell count
12/04/2003WO2003100382A1 Automatic point source biological agent detection system
12/04/2003WO2003100376A2 Hematological assay and kit
12/04/2003WO2003100101A1 Methods and apparati using single polymer analysis
12/04/2003WO2003100100A1 Methods and compositions for production of directed sequence libraries
12/04/2003WO2003100099A1 Parallel stranded duplexes of deoxyribonucleic acid and methods of use
12/04/2003WO2003100097A1 Fluorescence polarization detection of nucleic acids
12/04/2003WO2003100096A1 Application of cantilevers in nucleic acid sequencing
12/04/2003WO2003100095A1 Method of detecting target nucleic acid
12/04/2003WO2003100093A2 Method of selecting targets for gene silencing by rna interference
12/04/2003WO2003100092A2 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases
12/04/2003WO2003100091A1 Means and methods for improved treatment using 'setrones'
12/04/2003WO2003100090A2 Protein c polymorphisms
12/04/2003WO2003100089A1 Methods of modulating mitochondrial nad-dependent deacetylase
12/04/2003WO2003100088A2 Method and kit for measuring mitochondrial activity in human lymphocytes
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003100085A1 Screening for compounds having an effect on cells using microtiter plates
12/04/2003WO2003100084A1 A new biosensor
12/04/2003WO2003100083A1 Techniques to improve polyurethane membranes for implantable glucose sensors
12/04/2003WO2003100082A2 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003WO2003100077A2 Label-free detection of single nucleotide polymorphisms using surface plasmon resonance imaging
12/04/2003WO2003100076A2 Pna probes, probe sets, method and kits pertaining to the determination of listeria
12/04/2003WO2003100074A2 Animal genotyping method
12/04/2003WO2003100064A1 Novel ubiquitin ligase
12/04/2003WO2003100045A1 Plant thymidine kinases and their use
12/04/2003WO2003100035A2 Method for rapid detection and identification of viral bioagents
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100030A2 Kidney toxicity predictive genes
12/04/2003WO2003100028A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof
12/04/2003WO2003100024A2 Treatment for diabetes
12/04/2003WO2003100019A2 Nested pcr employing degradable primers
12/04/2003WO2003100014A2 Method for quantitating negative strand rna synthesis
12/04/2003WO2003100012A2 Microarrays and method for running hybridization reaction for multiple samples on a single microarray
12/04/2003WO2003100002A2 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
12/04/2003WO2003100001A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003WO2003100000A2 Amplification and overexpression of oncogenes
12/04/2003WO2003099998A2 Gene expression profiling of adult soft tissue sarcoma
12/04/2003WO2003099997A2 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003WO2003099996A2 Detection of secreted polypeptides
12/04/2003WO2003099957A1 Rnp immunoprecipitation assay
12/04/2003WO2003099846A2 System and method for screening for protease inhibitors and proteases
12/04/2003WO2003099802A1 POLYMERIC AMMONIUM AND OR PHOSPHONIUM SALTS HAVING ADDED π-ELECTRONS AND HIGHER MOLECULAR WEIGHT AS ENHANCERS FOR CHEMILUMINESCENT SYSTEMS
12/04/2003WO2003099801A1 Novel anti-infectives
12/04/2003WO2003099781A2 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
12/04/2003WO2003099780A2 Luminogenic protease substrates
12/04/2003WO2003099779A2 Hemipteran muscarinic receptor
12/04/2003WO2003099328A1 Methods and materials for treating inflammatory conditions
12/04/2003WO2003099325A1 Methods for the in vitro culture of sporozoea sp. and user thereof
12/04/2003WO2003099318A2 Pancreas-specific proteins
12/04/2003WO2003099312A1 Method for determining immune system affecting compounds
12/04/2003WO2003099229A2 Functional protein expression for rapid cell-free phenotyping
12/04/2003WO2003099228A2 Compositions and processes for inhibiting gene expression using polynucleotides
12/04/2003WO2003099219A2 Bryostatins, bryopyrans and polyketides: compositions and methods
12/04/2003WO2003099215A2 Antisense modulation of glucocorticoid receptor expression
12/04/2003WO2003099210A2 Methods of modulating tubulin deacetylase activity
12/04/2003WO2003099209A2 Compositions and methods for screening and identifying anti-hcv agents
12/04/2003WO2003099107A2 Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
12/04/2003WO2003099104A2 Elisa assay of serum soluble cd22 to assess tumor burden/relapse in subjects with leukemia and lymphoma
12/04/2003WO2003089897A3 Diagnosis and treatment of vascular disease
12/04/2003WO2003087356A3 Helicokinin-receptor from insects
12/04/2003WO2003079667A9 Improved nucleic acid amplification
12/04/2003WO2003078570A9 Multiple controls for molecular genetic analyses
12/04/2003WO2003076641A3 Method of detecting and quickly identifying pathogenic bacteria that can be transmitted through food using the real-time polymerase chain reaction
12/04/2003WO2003075838A3 Methods and compositions for pharmacological and toxicological evaluation of test agents
12/04/2003WO2003074738A8 Oligonucleotide-tagged semiconductor nanocrystals for microarray and fluorescence in situ hybridization
12/04/2003WO2003074548A3 Phage ligand sensor devices and uses thereof
12/04/2003WO2003070981A3 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
12/04/2003WO2003070891A3 Method of determining adenovirus particle concentration
12/04/2003WO2003068201A3 High affinity antibody having a tcr-like specificity and use in detection and treatment
12/04/2003WO2003065870A3 Digital amplification for detection of mismatch repair deficient tumor cells
12/04/2003WO2003063678A3 Streptococcus agalactiae in vitro diagnostic
12/04/2003WO2003060468A3 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease
12/04/2003WO2003060161A3 A method for assessing the potential responsiveness of a subject to anti-cancer drugs affecting the ras signal transduction pathway
12/04/2003WO2003060096A3 Assay for the detection of factors that modulate the expression of ingap
12/04/2003WO2003060070A3 Method of identifying novel proteins
12/04/2003WO2003059290A3 Diagnostic and therapeutic uses of topors
12/04/2003WO2003059285A3 Rip2: a method of signaling in the innate and adaptive immune systems
1 ... 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 ... 3003